FDA's New Focus On Opioids: Califf Confirmation Ploy?
This article was originally published in Scrip
Executive Summary
The FDA appears to be making a concerted effort in recent weeks to more thoroughly examine how it regulates prescription opioids – a topic that's been a hot button issue on Capitol Hill and at the heart of a handful of lawmakers' attempts to try to prevent Robert Califf from becoming commissioner of the agency.